NuCana plc (NASDAQ: NCNA)
$3.01
-0.0900 ( -2.90% ) 28.5K
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Market Data
Open
$3.01
Previous close
$3.10
Volume
28.5K
Market cap
$6.96M
Day range
$3.02 - $3.12
52 week range
$2.53 - $21.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Nov 13, 2023 |
6-k | Quarterly Reports | 2 | Oct 16, 2023 |
6-k | Quarterly Reports | 2 | Oct 13, 2023 |
6-k | Quarterly Reports | 2 | Sep 18, 2023 |
6-k | Quarterly Reports | 56 | Aug 16, 2023 |